February 1st, 2010
J Invest Dermatol. 1990 Dec;95(6):683-7. Links
Price, et al
Regrowth of hair over a 40-week period is reported for eight women with pattern hair loss. The women were given either a 2% minoxidil solution or a placeb only. Hair on the scalp was pulled through a lastic template, and the outline of the template was drawn. The hair was clipped and collected at five eight-week intervals (one untreated and four treated). Subsequent measurements included the total weight of hair regrown in the marked area, the total number of hairs. Calculated quantities included average weight per hair, average length, and average optical width. The average total hair weight of minoxidil-treated subjects increased over the 32-week test period by 42.5%, compared to 1.9% for the placebo-treated subjects. Changes for the average number count were 29.9% and -2.6%, respectively. These increases, observed using an unusually small number of subjects, clearly distinguished the treated subjects from the untreated. During the same test period, the averaged quantities of weight, diameter, and length from the 50-hair subsample showed insignificant change (p usually greater than 0.5). In addition to showing a larger percentage increase than did the total number, the total weight is not only easier to obtain, but less prone to error during sampling and measurement. Therefore, we recommend that total weight from a defined area be considered as the primary quantitative estimator for hair regrowth.
edited for hair loss treatment blog use
Posted in Uncategorized | No Comments »
January 1st, 2010
Posted in Uncategorized | No Comments »
December 28th, 2009
Hair Loss Treatment at the Proctor Clinic
Posted in Uncategorized | No Comments »
December 25th, 2009
Cell Sci. 1990;97:463.
Human hair growth in vitro.
Philpott MP, et al
We report for the first time the successful maintenance and regrowth of human hair follicles in vitro. Human anagen hair follicles were isolated by microdissection from human scalp skin. Isolation of the hair follicles was achieved by cutting the follicle at the dermo-subcutaneous fat interface using a scalpel blade. Intact hair follicles were then removed from the fat using watchmakers’ forceps. Isolated hair follicles maintained free-floating in supplemented Williams E medium in individual wells of 24-well multiwell plates showed a significant increase in length over 4 days. The increase in length was seen to be attributed to the production of a keratinised hair shaft, and was not associated with the loss of hair follicle morphology. …snip…
edited for blog
Posted in Uncategorized | No Comments »
December 21st, 2009
Hair loss treatment at the Proctor Clinic
Posted in Uncategorized | No Comments »
December 2nd, 2009
European Journal of Dermatology. Volume 11, Number 4, 293-5, July – August 2001, Articles de la revue
Author( : S. Andersson,
The gonadal synthesis of testosterone from cholesterol involves cytochrome P-450 side-chain cleavage enzyme, cytochrome P-450 17a-hydroxylase, 3b-hydroxysteroid dehydrogenase, and 17b-hydroxysteroid dehydrogenase. A significant part of testosterone is converted in androgen target tissues to the more potent androgen dihydrotestosterone by the steroid 5a-reductase isoenzymes. Dihydrotestosterone, which binds to the nuclear androgen receptor with much greater affinity than testosterone, is the androgen responsible for male pattern hair loss. Consequently, the 5a-reductase inhibitor finasteride was developed and has proven efficacious in promoting hair regrowth. Likewise, C19-steroids produced by glandular and peripheral tissues may also feed into skin production of dihydrotestosterone, oxidative 3a-hydroxysteroid dehydrogenase, and 3b-hydroxysteroid dehydrogenase enzymes. Aberrant expression of one or more of these enzymes could conceivably result in increased scalp dihydrotestosterone levels, acceleration of the balding process in men and women.
Posted in Uncategorized | No Comments »
November 27th, 2009
Sehgal VN, Bhattacharya SN, Sharma S, Srivastava G, Aggarwal AK. Alopecia areata progressing to totalis/universalis in non-insulin dependent diabetes mellitus (type II): Failure of dexamethasone-cyclophosphamide pulse therapy. Indian J Dermatol Venereol Leprol [serial online] 2008 [cited 2009 Nov 27];74:171-3.
…A 47-year-old man….had a few recalcitrant multiple boils on the nape of the neck. His fasting and postprandial blood sugar levels were markedly elevated ..snip… treated with antibiotics … Four months later, he experienced spontaneous loss of hair over the legs progressing to involve other sites. In a short period of time, hair loss was noticed over the trunk, scalp and the beard area. It was accompanied by mild to moderate itching. However, hair loss was not preceded by any perifollicular papular or pustular lesions. The loss of hair over the scalp was total and was a source of embarrassment…. Examination of the skin was marked by loss of hair over the whole of the skin surface of the trunk, upper and lower extremities with patches of hair loss over the beard area. Hair pull test was positive. The complete loss of hair over the scalp was without any evidence of scarring or any skin lesion.. snip
Posted in Uncategorized | 2 Comments »
November 25th, 2009
Prague Med Rep. 2009;110(3):222-30.
Finasteride treatment and neuroactive steroid formation.
Dusková M,.
Finasteride is the 5alpha-reductase inhibitor that received clinical approval for the treatment of human benign prostate hyperplasia and male pattern hair loss. The 5alpha-reductase is enzyme responsible for the reduction of testosterone to dihydrostestosterone, progesterone to dihydroprogesterone and deoxycorticosterone to dihydrodeoxycorticosterone, steroids modulating the action of gamma-aminobutyric acid on GABA receptors. These neuroactive steroids possess anticonvulsant, antidepressant and anxiolytic effects. snip.. In the course of finasteride treatment of hair loss the decrease of the concentration of circulating steroids with known inhibitory activity on GABA-ergic excitation in the brain is very probably an important factors contributing to the development of the symptoms of depression seen in some isolated cases of finasteride administration.
Posted in Uncategorized | No Comments »
November 17th, 2009
Posted in Uncategorized | No Comments »
November 15th, 2009
Dermatologica. 1987;175:19
….Minoxidil: possible mechanisms of action.
Headington JT.
The mechanism by which minoxidil, whether given orally or applied topically, stimulates hair regrowth remains undetermined. Possible indirect drug action, such as vasodilatation and increased blood flow to the dermal papilla, or possible local irritation related to minoxidil or to one or more components of the vehicle used for topical application has been suggested. …snip…Shortening and diminution of follicle size is undoubtedly accompanied by shortening of the hair growth cycle (decreased anagen time). Morphometric evaluation of scalp biopsies of patients receiving topical minoxidil in a vehicle composed of propylene glycol, water and ethanol has revealed growth of larger normally formed follicles when compared with pretreatment biopsies from the same individual. There has been no suggestion in any morphologic studies of minoxidil-treated patients for development of new follicles. Because the dermal papilla of the hair follicle apparently controls both regrowth and differentiation of hair matrix cells and because there are not dysplastic or atypical changes in fgerminal epithelium after minoxidil, it is concluded that the most probable site for the action of minoxidil in hair loss is on the cells of the papilla.
edited for hair loss blog use
Posted in Uncategorized | 2 Comments »